Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Our unwavering commitment to advancing patient care is demonstrated every day. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.
Webcast ImageWebcast
Jazz Pharmaceuticals at UBS Global Healthcare Conference (Replay)
05/20/15 at 8:00 a.m. ET
Webcast ImageWebcast
Jazz Pharmaceuticals at Goldman Sachs 36th Annual Global Healthcare Conference (Live)
06/10/15 at 10:40 a.m. PT
Press Releases
May 15 2015 - 4:06 p.m.
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
May 07 2015 - 4:05 p.m.
Jazz Pharmaceuticals Announces First Quarter 2015 Financial Results
May 07 2015 - 4:05 p.m.
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update


Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.